<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">APM</journal-id><journal-title-group><journal-title>Advances in Precision Medicine</journal-title></journal-title-group><issn>2424-8592</issn><eissn>2424-9106</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/APM.v11i8.16069</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Observation on the Clinical Effect of Secondary Prevention Intervention Using Integrated Traditional Chinese and Western Medicine in Outpatient Ischemic Stroke Patients</title><url>https://artdesignp.com/journal/APM/11/8/10.26689/APM.v11i8.16069</url><author>LiuWeihong</author><pub-date pub-type="publication-year"><year>2026</year></pub-date><volume>11</volume><issue>8</issue><history><date date-type="pub"><published-time>2026-08-26</published-time></date></history><abstract>Objective: To analyze the specific content of secondary prevention intervention using integrated traditional Chinese and Western medicine to explore the application value for outpatient ischemic stroke patients. Methods:&amp;nbsp;Composition of research subjects: Ischemic stroke patients were all from the outpatient department of our hospital, a total of 70 cases. After grouping according to the random number table method, 35 cases were included in each group. After investigation, the above patients were selected from June 2025 to June 2026; during the treatment phase, conventional Western medicine secondary prevention measures were used in the control group, and combined Chinese and Western medicine secondary prevention measures were used in the experimental group to compare the effects. Results:&amp;nbsp;(1) After sorting out the research data of patients with ischemic stroke, the difference in NIHSS scores before intervention was small, P&amp;gt;0.05; after intervention, the experimental group was lower than the control group, P&amp;lt;0.05; (2) FMA scores and Barthel index were compared, and the difference before intervention was small, P&amp;gt;0.05; after intervention, the experimental group was higher, P&amp;lt;0.05; (3) In terms of total effective rate, the calculated data of ischemic stroke patients in the two groups were: 77.14% (27/35), 94.29% (33/35). The comparison results showed that the experimental group was higher, P&amp;lt;0.05; (4) The incidence of adverse reactions and stroke recurrence rate were compared, the experimental group was lower, P&amp;lt;0.05. Conclusion:&amp;nbsp;In the outpatient treatment stage, the application of integrated traditional Chinese and Western medicine for secondary prevention has significant advantages in many aspects. For patients with ischemic stroke, it is beneficial for improving the degree of neurological deficits, promoting the early recovery of limb motor functions and daily life activities, and ensuring the best efficacy. More importantly, the implementation of this measure can reduce the incidence of adverse reactions and stroke recurrence rates in patients. It is safe and deserves further promotion.</abstract><keywords>Integrated traditional Chinese and Western medicine, Secondary prevention intervention, Outpatient ischemic stroke patients, Effect analysis</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>[1] Li PY, Zhou WM, 2026, Research on the Effectiveness of &amp;ldquo;Hospital-Community-Family&amp;rdquo; Standardized Pharmaceutical Science Popularization Led by Clinical Pharmacists in the Secondary Prevention of Ischemic Stroke. Chinese Prescription Drugs, 24(9): 53&amp;ndash;57.
[2] Li MZ, 2025, Research Progress on the Treatment Mechanism and Clinical Translation of Integrated Traditional Chinese and Western Medicine for Ischemic Stroke of &amp;ldquo;Qi Deficiency and Blood Stasis&amp;rdquo; Type. Journal of Neurology and Neurorehabilitation, 21(3): 238&amp;ndash;247.
[3] Li WW, Zhao MM, Wang HY, 2026, Effect of HFMEA Intervention in Emergency Management of Patients with Acute Ischemic Stroke. Medical Clinical Research, 43(2): 317&amp;ndash;320.
[4] Wu YY, Fan L, 2023, Rehabilitation Effect of Full-Care Clinical Decision Support System on Patients with Ischemic Stroke. Henan Medical Research, 32(1): 173&amp;ndash;176.
[5] Cao SY, 2023, The Application Value of Seamless Emergency Nursing Model in Patients with Acute Ischemic Stroke. Practical Clinical Integration of Traditional Chinese and Western Medicine, 23(3): 113&amp;ndash;117.
[6] Zhang YH, 2024, Clinical Observation on the Treatment of Ischemic Stroke with Integrated Traditional Chinese and Western Medicine. Guangming Traditional Chinese Medicine, 39(6): 1064&amp;ndash;1067.
[7] Zhang BY, Li J, Yao Y, et al., 2024, Construction and Application Research of Cognitive Intervention Program for Secondary Prevention of Medication Compliance in Community Ischemic Stroke Patients. Chinese Nursing Education, 21(9): 1099&amp;ndash;1106.
[8] Zhou JM, Zhang MH, Ge XL, et al., 2024, Observation on the Clinical Efficacy of Integrated Traditional Chinese and Western Medicine in the Treatment of Acute Ischemic Stroke. Chinese Medical Sciences, 14(20): 70&amp;ndash;73.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
